by Clinical Neuropsychologist | Tuesday, February 4, 2025 | Neuroimaging
ABSTRACT Background and Purpose Silent brain infarcts (SBIs), which manifest as dot-like lesions on diffusion-weighted imaging (DWI) after endovascular procedures, are associated with an increased risk of stroke, dementia, and cognitive decline. We aimed to identify...
by Clinical Neuropsychologist | Friday, January 24, 2025 | Neuroimaging
ABSTRACT Intracranial pressure (ICP) monitoring is a cornerstone of neurocritical care in managing severe brain injury. However, current invasive ICP monitoring methods carry significant risks, including infection and intracranial hemorrhage, and are contraindicated...
by Clinical Neuropsychologist | Wednesday, January 22, 2025 | Neuroimaging
ABSTRACT Background and Purpose The central vein sign (CVS) is a diagnostic imaging biomarker for multiple sclerosis (MS). FLAIR* is a combined MRI contrast that provides high conspicuity for CVS at 3 Tesla (3T), enabling its sensitive and accurate detection in...
by Clinical Neuropsychologist | Tuesday, January 21, 2025 | Neuroimaging
ABSTRACT Background and purpose Prolonged length of stay (LOS) following a stroke is associated with unfavorable clinical outcomes. Factors predicting LOS in medium vessel occlusion (MeVO), impacting up to 40% of acute ischemic stroke (AIS) cases, remain...
by Clinical Neuropsychologist | Thursday, January 16, 2025 | Neuroimaging
ABSTRACT Background and Purpose MRI is crucial for multiple sclerosis (MS), but the relative value of portable ultra-low field MRI (pULF-MRI), a technology that holds promise for extending access to MRI, is unknown. We assessed white matter lesion (WML) detection on...
by Clinical Neuropsychologist | Wednesday, January 15, 2025 | Neuroimaging
ABSTRACT Background and Purpose Prolonged venous transit (PVT), derived from computed tomography perfusion (CTP) time-to-maximum (T max) maps, reflects compromised venous outflow (VO) in acute ischemic stroke due to large vessel occlusion (AIS-LVO). Poor VO is...
